Amyotrophic lateral sclerosis Machine learning Antiphospholipid syndrome Deep immune profiling Anti-synthetase syndrome Cytokines Biopsy Prognosis Adjudication Acid-alpha-glucosidase AAV antibody Autoimmune diseases Antibody responses Antisynthétase Anti-interleukin-6 Inclusion body myositis Anticorps spécifique des myosites Gene therapy IBM B-lymphocyte Sphingosine-1-phosphate Adeno-associated vector Biomarker Myositis Outcome measures Adeno-associated virus Immune checkpoint inhibitors Skeletal muscle Acute Kidney Injury/epidemiology/etiology Interstitial lung disease Dermatomyositis Amyotrophy Antisynthetase Anémie hémolytique Anti-drug antibodies Auto-immunité Active Male Arthritis Animals Systems biology Case reports AAV Adolescence Inflammation Anticorps anti-agalsidase Adult Aged Autoantibody AAV vectors Inborn errors of metabolism Immunotherapy Cancer Auto‐antibodies Inflammatory myopathy Anti-IgE IgG CD8+T cells Mass cytometry Anti‐mitochondrial antibodies AAV humoral immunity Dependovirus/genetics/immunology Adverse drug reactions Auto-antibodies Abnormal movement AAV vector Assisted communication devices Analyses multidimensionnelles B cell homeostasis Myocarditis Antibodies Humans Myositis and muscle disease Myopathy Biomarqueurs Middle Aged Anti-MDA5 autoantibodies DM IMNM Idiopathic inflammatory myopathies Anti-agalsidase antibodies Muscle Aldostérone Antisynthetase syndrome CD8+ T-bet+ cells Agalsidase Bioelectrical impedance analysis Anti-Mi2 Autoimmunity Biomarkers Adeno-associated virus vector Multidisciplinarity COVID-19 Aldosterone Polymyositis Autoantibodies Data integration Fabry disease Female Interferon Lysosomal storage diseases